Article Details
Retrieved on: 2025-10-01 16:43:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA interference medicines past ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here